Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| October 17th, 2024 |
CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
| August 1st, 2022 |
DEGRA Follow-on/Djibouti Basic Education Activity |
Ethiopia USAID Addis Ababa |
| August 8th, 2022 |
USAID/Ethiopia Empowering Community Activity |
Ethiopia USAID Addis Ababa |
| February 17th, 2023 |
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) |
National Institutes of Health |
| February 17th, 2023 |
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
| January 9th, 2023 |
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 2nd, 2023 |
HEAL Initiative: Rapidly Assessing the Public Health Impact of Emerging Opioid Threats (UG1 - Clinical Trial Not Allowed) |
National Institutes of Health |
| May 8th, 2023 |
Overdose Data to Action: Limiting Overdose through Collaborative Actions in Localities (OD2A: LOCAL) |
Centers for Disease Control NCIPC |
| April 17th, 2023 |
Building capacity for implementing evidence-based epilepsy self-management supports in health care settings |
Centers for Disease Control NCCDPHP |
| February 2nd, 2023 |
HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 - Clinical Trial Optional) |
National Institutes of Health |
| October 19th, 2022 |
Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional) |
National Institutes of Health |
| October 5th, 2022 |
Impact of the Microbiome-Gut-Brain Axis on Alzheimer's Disease and Alzheimer's Disease-Related Dementias (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 22nd, 2022 |
Harnessing Technologies to Support Oral Health Promotion and Management Outside the Dental Setting (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
| December 1st, 2022 |
National Coordinating Center for the George M. OBrien Kidney National Resource Centers (U24 - Clinical Trial Not Allowed) |
National Institutes of Health |
| December 1st, 2022 |
George M. O'Brien Kidney National Resource Centers (U54 - Clinical Trial Not Allowed) |
National Institutes of Health |
| November 8th, 2022 |
New Approaches for Incorporating Genetic Diversity into Toxicity Testing (R43/R44 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 6th, 2022 |
PEPFAR Community Led Monitoring (CLM)-Zambia |
US Mission to Zambia |
| November 15th, 2022 |
Enabling SUD Digital Therapeutics Research to Improve Payor Adoption (R44- Clinical Trial Only) |
National Institutes of Health |
| June 26th, 2025 |
NIDDK Central Repository Non-renewable Sample Access (X01 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 30th, 2022 |
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional) |
National Institutes of Health |
|
| September 7th, 2025 |
NIDA Program Project Grant Applications (P01 Clinical Trial Optional) |
National Institutes of Health |
| May 22nd, 2023 |
Annual Program Statement - Public Diplomacy Small Grants |
US Mission to India |
| July 15th, 2024 |
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 1st, 2023 |
Advancing Policy as a Public Health Intervention to Reduce Morbidity, Mortality and Disparities in HIV, Viral Hepatitis, STDs, and Tuberculosis |
Centers for Disease Control NCHHSTP |
| July 25th, 2022 |
Community Monitoring Activity (CLM) |
South Sudan (USAID) Juba |
| December 7th, 2022 |
Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 7th, 2022 |
Structural Biology of Alzheimer's Disease Related Dementias (ADRDs) Proteinopathies (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 18th, 2022 |
Therapeutic Development of Psychoplastogenic Compounds for Substance Use Disorders (R43/R44 - Clinical Trials Not Allowed) |
National Institutes of Health |
| August 3rd, 2022 |
MOMENTUM Yemen Round |
Kenya USAID Nairobi |
| September 7th, 2025 |
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) |
National Institutes of Health |
| September 7th, 2025 |
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) |
National Institutes of Health |
| November 23rd, 2022 |
Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 29th, 2022 |
Domestic Violence Prevention Enhancement and Leadership Through Alliances (DELTA): Achieving Health Equity through Addressing Disparities (AHEAD) |
Centers for Disease Control NCIPC |
| September 5th, 2025 |
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) |
National Institutes of Health |
| July 31st, 2022 |
Rural Decentralized Water System Grant Program |
Rural Utilities Service |
| July 31st, 2022 |
Revolving Fund Program |
Rural Utilities Service |
| March 20th, 2023 |
The Sudden Unexpected Infant Death (SUID) and Sudden Death in the Young (SDY) Case Registry |
Centers for Disease Control NCCDPHP |
| September 5th, 2025 |
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
| March 3rd, 2023 |
Dental Faculty Loan Repayment Program |
Health Resources and Services Administration |
| March 21st, 2023 |
Integrated Substance Use Disorder Training Program (ISTP) |
Health Resources and Services Administration |
